Effects of Vivatlac Synbiotikum in Patients With Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Vivatlac Synbiotikum

Each capsule of Vivatlac® Synbiotikum contains a total of 4.5 x 10˄9 colony forming units (CFU) of nine different probiotic bacteria. Probiotic bacteria strains and their CFU amount per capsule are: Lactococcus lactis Ll-23, 9.00 x 10˄8 CFU; Lactobacillus helveticus SP 27, 9.00 x 10˄8 CFU; Bifidobacterium longum Bl-05, 6.75 x 10˄8 CFU; Bifidobacterium breve Bb-03, 4.50 x 10˄8 CFU; Lacticaseibacillus rhamnosus Lr-32, 4.50 x 10˄8 CFU; Streptococcus thermophiles St-21, 4.50 x 10˄8 CFU; Lacticaseibacillus casei Lc-11, 2.25 x 10˄8 CFU; Lactiplantibacillus plantarum Lp-115, 2.25 x 10˄8 CFU; Bifidobacterium bifidum Bb-02, 2.25 x 10˄8 CFU. As a prebiotic component each capsule contains 63 mg of fructooligosaccharides.

Trial Locations (2)

27-230

"Family doctor's outpatient clinic Panacea", Krynki

62-820

Family doctor's clinic, Stawiszyn

All Listed Sponsors
lead

The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz

OTHER